This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page | Contact Us | Report Abuse | Sign In | Join Us
News & Press: News

Join the Medicines Optimisation Working Group

13 July 2017   (0 Comments)
Posted by: Heather Smith
Share |

One of the ECHAlliance’s membership benefits is to join one of the International Working Groups. You now have an opportunity to join the Medicines Optimisation Working Group (MOWG) chaired by Prof Mike Scott, Head Pharmacy & Medicines Management, Northern Health and Social Care Trust, Northern Ireland and attend the next call. MOWG is a reference point to support current work and potential future ventures for the Ecosystem International Network. 

The group acts as a forum to test thinking, share best practice and provide advice on developments, supporting the scale up and spread of innovations. MOWG will obtain other professional advice from internal or external sources as necessary and feedback on findings where applicable. 

Calls are scheduled on regular basis every 6 weeks with an agenda shaped by the participants in the group. An attempt will be made to hold a face to face meeting in the coming months. Some of the current objectives and topics for discussion include, but are not limited to:

  • agree a common definition and understanding of the term Medicines Optimisation (MO)
  • identify current MO landscape(s) and key priorities, that if addressed would drive improved outcomes for patients, carers and wider health economies
  • identify examples of ‘good’ MO strategies and share best practice in relation to MO strategies
  • identify gaps for enabling technologies in MO improvement
  • share best practice in relation to enabling technologies with regard to medicines optimisation processes
  • have a horizon scanning function and facilitate knowledge transfer
  • identify and seek to access funding for both research and development, as well as innovation in medicines optimisation processes and technologies
  • identify matchmaking opportunities and facilitate exchange visits for shared learning
  • organise appropriate dissemination events via e.g. conferences, workshops, webinars
  • provide a forum to enable collaboration between industry, patient groups academia and health authorities 

The next call is on 3 August at 14:30 CET. If you are a member and interested in registering or if you have any questions on how to become a member of ECHAlliance, please contact:

Heather Smith, or Mikaela Nordenfelt,